CN Patent

CN107028908A — 对乙酰氨基酚/曲马多口服延释剂型

Assigned to Alza Corp · Expires 2017-08-11 · 9y expired

What this patent protects

本发明涉及对乙酰氨基酚/曲马多口服延释剂型。本发明公开了对乙酰氨基酚和曲马多的延释口服剂型。所述剂型包括对乙酰氨基酚和采用阴离子聚合物形成的曲马多复合物一起的组合物。所述曲马多复合物提供曲马多的持续释放，以得到对乙酰氨基酚和曲马多的同步(协同)释放曲线。

USPTO Abstract

本发明涉及对乙酰氨基酚/曲马多口服延释剂型。本发明公开了对乙酰氨基酚和曲马多的延释口服剂型。所述剂型包括对乙酰氨基酚和采用阴离子聚合物形成的曲马多复合物一起的组合物。所述曲马多复合物提供曲马多的持续释放，以得到对乙酰氨基酚和曲马多的同步(协同)释放曲线。

Drugs covered by this patent

Patent Metadata

Patent number
CN107028908A
Jurisdiction
CN
Classification
—
Expires
2017-08-11
Drug substance claim
No
Drug product claim
No
Assignee
Alza Corp
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.